Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Carcinoma, Hepatocellular 3Prostatic Neoplasms 2Liver Neoplasms 2Hemangiosarcoma 2Glioblastoma 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Sarcoma 1Ovarian Neoplasms 1Oligodendroglioma 1Neoplasms 1Lung Neoplasms 1Liver Neoplasms, Experimental 1Gliosarcoma 1Glioma 1Fallopian Tube Neoplasms 1Choriocarcinoma 1Carcinoma, Transitional Cell 1Carcinoma, Renal Cell 1Brain Neoplasms 1Astrocytoma 1Adult Solid Tumor 1Adenoma, Liver Cell 1

Interventions

Doxorubicin 11Ifosfamide 10Radiotherapy 7pazopanib 4Imatinib Mesylate 3Filgrastim 3Etoposide 3Epirubicin 3Chemotherapy, Adjuvant 3Bevacizumab 3cixutumumab 2carotuximab 2belinostat 2Vincristine 2Sunitinib 2Sorafenib 2Radiotherapy, Conformal 2Paclitaxel 2Gemcitabine 2Dactinomycin 2Cyclophosphamide 2Carboplatin 2tremelimumab 1trebananib 1temsirolimus 1soblidotin 1romidepsin 1ribociclib 1regorafenib 1perifosine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Hemangiosarcoma × carotuximab × Clear all
NCT01975519 2020-05-20

A Phase 1B Dose-escalation and Phase 2a Study of Carotuximab (TRC105) in Combination With Pazopanib in Patients With Advanced Soft Tissue Sarcoma

Tracon Pharmaceuticals Inc.

Phase 1/2 Completed
111 enrolled 15 charts
Sarcoma

Hemangiosarcoma, Sarcoma

NCT02979899 2020-05-12

TAPPAS

Tracon Pharmaceuticals Inc.

Phase 3 Completed
128 enrolled 13 charts
Sarcoma

Hemangiosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡